Survodutide CAS 2805997-46-8

Deskripsyon pwodwi:

Non pwodwi: Survodutide CAS 2805997-46-8

 

Sinonim:

18-[[4-[[2-[[(2R)-1-[[2-[[(2R)-1-[[{{ 8}}[[2-[[(5R)-5-[[(2S,3S)-2-[[(2S)-2-[[(2S){{18 }}[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[ (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino{ {38}}[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R) )-2-[[(2S)-2-[[(2S,3R){-2-[[2-[[(2S)-5-amino{{58} [[1-[[(2S)-2-amino{-3-(1H-imidazol-4-il)propanoyl]amino]cyclobutanecarbonyl]amino]-5-oxopentanoyl] amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]{-3-hydroxypropanoyl]amino]{-3-carboxypropanoyl]amino ]-3-({4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-({4-hydroxyphenyl)propanoyl]amino]{{ 77}}methylpentanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]propanoyl]amino]hexanoyl]amino]{{81} }carboxypropanoyl]amino]-3-fenilpropanoil]amino]-3-methylpentanoyl]amino]-6-[[(2R)-1-[[(2R)-1-[[[ (2R)-1-[[(2R)-1-[[(2R)-1-amino-1-oxopropan-2-il]amino]-3-idwoksi -1-oxopropan-2-il]amino]-4-carboxy{-1-oxobutan{-2-il]amino]{-4-metil{-1-oksopentan{{ 105}}il]amino]-3-(1H-indol-3-il)-1-oxopropan{-2-il]amino]{-6-oxohexyl]amino]{{113 }}oxoethyl]amino]-2-oxoethyl]amino]-3-idwoksi-1-oxopropan{-2-il]amino]{-2-oxoethyl]amino]-3- idroksi-1-oksopropan{-2-il]amino]{-2-oksoetil]amino]-1-karboks{-4-oksobutil]amino]-18-oxooctadecanoic asid;

 

Pwopriyete chimik ak fizik:

Aparans: poud blan ak blan

Egzamen: Pi gran pase oswa egal a 99.0%

 

Itilizasyon

Survodutide se yon agonist reseptè glucagon ak glucagon tankou peptide-1 (GLP-1).

 

 

Si w enterese nan pwodwi nou yo oswa si w gen nenpòt kesyon, tanpri ou lib pou kontakte nou!

 

 

Pwodwi anba patant yo ofri pou rezon R & D sèlman. Sepandan, responsablite final la se sèlman nan achtè a.

Baj popilè: survodutide cas 2805997-46-8, manifaktirè, founisè, faktori, achte, nan stock

• On: Fruquintinib CAS 1194506-26-7
• Pwochen: Fmoc-Lys (Boc) (izopropil)-OH CAS 201003-48-7